Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: BIOCRYST PHARMACEUTICALS INC
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2018-09-01 to 2023-08-31
Current total value of award: $34660000
Description: PERAMIVIR, RAPIVAB FLU TREATMENT